Fig. 2From: A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancera Incidence of neutropenia, all grades. b Incidence of grade 3/4 neutropenia. c Incidence of leukopenia, all grades. d Incidence of grade 3/4 leukopenia. e Incidence of peripheral sensory neuropathy, all grades. f Incidence of grade 3/4 peripheral sensory neuropathy. g Incidence of fatigue, all grades. h Incidence of grade 3/4 fatigueBack to article page